Charles Schwab’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,061,176
Closed -$195M 3593
2021
Q2
$195M Buy
1,061,176
+27,593
+3% +$5.07M 0.06% 271
2021
Q1
$158M Sell
1,033,583
-53,350
-5% -$8.16M 0.06% 297
2020
Q4
$170M Sell
1,086,933
-229,255
-17% -$35.8M 0.07% 261
2020
Q3
$151M Sell
1,316,188
-111,051
-8% -$12.7M 0.07% 250
2020
Q2
$160M Buy
1,427,239
+63,205
+5% +$7.09M 0.08% 233
2020
Q1
$122M Sell
1,364,034
-38,250
-3% -$3.43M 0.07% 251
2019
Q4
$152M Buy
1,402,284
+115,764
+9% +$12.5M 0.08% 224
2019
Q3
$126M Buy
1,286,520
+33,791
+3% +$3.31M 0.07% 255
2019
Q2
$164M Buy
1,252,729
+59,132
+5% +$7.75M 0.1% 192
2019
Q1
$161M Buy
1,193,597
+242,174
+25% +$32.7M 0.1% 181
2018
Q4
$92.6M Buy
951,423
+71,266
+8% +$6.94M 0.07% 252
2018
Q3
$122M Buy
880,157
+3,551
+0.4% +$494K 0.08% 224
2018
Q2
$109M Sell
876,606
-44,119
-5% -$5.48M 0.08% 232
2018
Q1
$103M Buy
920,725
+13,920
+2% +$1.55M 0.08% 243
2017
Q4
$108M Buy
906,805
+56,472
+7% +$6.75M 0.09% 218
2017
Q3
$119M Buy
850,333
+54,761
+7% +$7.68M 0.1% 184
2017
Q2
$96.8M Buy
795,572
+97,659
+14% +$11.9M 0.09% 217
2017
Q1
$84.6M Buy
697,913
+57,455
+9% +$6.97M 0.08% 229
2016
Q4
$78.4M Buy
640,458
+12,731
+2% +$1.56M 0.09% 227
2016
Q3
$76.9M Buy
627,727
+14,600
+2% +$1.79M 0.09% 227
2016
Q2
$71.6M Buy
613,127
+11,923
+2% +$1.39M 0.09% 230
2016
Q1
$83.7M Buy
601,204
+22,758
+4% +$3.17M 0.11% 173
2015
Q4
$110M Buy
578,446
+29,410
+5% +$5.61M 0.15% 130
2015
Q3
$85.9M Sell
549,036
-11,392
-2% -$1.78M 0.13% 155
2015
Q2
$101M Buy
560,428
+81,607
+17% +$14.8M 0.14% 141
2015
Q1
$83M Buy
478,821
+30,105
+7% +$5.22M 0.12% 173
2014
Q4
$83M Sell
448,716
-9,102
-2% -$1.68M 0.12% 165
2014
Q3
$75.9M Buy
457,818
+9,511
+2% +$1.58M 0.12% 162
2014
Q2
$70M Buy
448,307
+15,982
+4% +$2.5M 0.12% 176
2014
Q1
$65.8M Buy
432,325
+42,841
+11% +$6.52M 0.12% 176
2013
Q4
$51.8M Buy
389,484
+17,105
+5% +$2.28M 0.1% 201
2013
Q3
$43.7M Buy
372,379
+18,285
+5% +$2.15M 0.09% 227
2013
Q2
$33.9M Buy
+354,094
New +$33.9M 0.08% 249